About Familial atypical multiple mole melanoma syndrome
Familial atypical multiple mole melanoma syndrome is a rare disease catalogued by Orphanet (ORPHA:404560). It is associated with the CDKN2A gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Familial atypical multiple mole melanoma syndrome trials.
Search ClinicalTrials.gov for "Familial atypical multiple mole melanoma syndrome" or filter by Orphanet code ORPHA:404560 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Familial atypical multiple mole melanoma syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Familial atypical multiple mole melanoma syndrome. Updated daily.